Riskpilot← Back to searchSign inGet full accessDOKTORVEI1 AS
ASActiveOrg 924705825Øya 5, 3262 LarvikDevelopment of building projects · NACE 6812Est. 20200 employees
Revenue 2024
NOK 109K
EBITDA margin
17.1%
+470% vs 2023
Equity ratio
0.5%
Financial strength
Net profit 2024
NOK 19K
+472% vs 2023
| Revenue | NOK 109K | — |
| EBITDA | NOK 19K | +470% |
| Net profit | NOK 19K | +472% |
| Total assets | NOK 3M | +2099% |
| Equity | NOK 16K | +755% |
| Employees | 0 | — |
Legal name
DOKTORVEI1 AS
Org number
924705825
Legal form
Aksjeselskap
NACE code
6812 · Development of building projects
Founded
5. mars 2020
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Utvikling, kjøp og salg av fast eiendom, investering i aksjer og verdipapir, samt deltakelse i andre selskaper.
Address
Øya 5, 3262 Larvik
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 109 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −6 | −4 | −18 | −5 | 19 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −6 | −4 | −18 | −5 | 19 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −6 | −4 | −18 | −5 | 19 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −6 | −4 | −18 | −5 | 19 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 24 | 21 | 4 | 139 | 3 046 |
| Equity | 24 | 21 | 3 | −2 | 16 |
| Long-term debt | 0 | 0 | 0 | 141 | 3 030 |
| Short-term debt | 0 | 0 | 1 | 0 | 0 |
| Total debt | 0 | 0 | 1 | 141 | 3 030 |
EBITDA margin
17.1%
This company
15.8%
Market median
+8% vs market
20202024
Equity ratio
0.5%
This company
38.2%
Market median
-99% vs market
20202024
Return on equity
115.3%
This company
18.4%
Market median
+527% vs market
20202024
Net profit margin
17.2%
This company
8.1%
Market median
+112% vs market
20202024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
186.15×
This company
0.62×
Market median
-29924% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HM Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 | |
| Company | 50% | 50% | 2024 | |
| Company | 50% | 50% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Patek Eiendom As
DOKTORVEI1 AS Board members of DOKTORVEI1 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Håkon Morris Blikstad | Chief Executive Officer | 0 companies |
| Bruno Strøm | Board of Directors | 0 companies |
| Dag Martin Trulsen | Chairman | 0 companies |